meriofert 150 iu injektiokuiva-aine ja liuotin, liuosta varten
ibsa farmaceutici italia s.r.l - menotropine - injektiokuiva-aine ja liuotin, liuosta varten - 150 iu - menotropiini
meriofert 75 iu injektiokuiva-aine ja liuotin, liuosta varten
ibsa farmaceutici italia s.r.l - menotropine - injektiokuiva-aine ja liuotin, liuosta varten - 75 iu - menotropiini
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - diabeetilla käytettävät lääkkeet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
ringer-acetat fresenius kabi infuusioneste, liuos
fresenius kabi ab - calcium chloride dihydrate, potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate, sodium chloride - infuusioneste, liuos - elektrolyytit
ultracain d-suprarenin 40 mg/ml + 5 mikrog/ml injektioneste, liuos
sanofi oy - adrenaline hydrochloride, articaine hydrochloride - injektioneste, liuos - 40 mg/ml + 5 mikrog/ml - artikaiini
isofluran baxter inhalaatiohöyry, neste
baxter oy - isoflurane - inhalaatiohöyry, neste - isofluraani